The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis

The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis

<p><strong>Objective</strong>: To evaluate the comparative cardiovascular safety of incretin-based therapies in patients with type 2 diabetes mellitus (T2DM).</p> <p><strong>Methods</strong>: Medline, Embase, the Cochrane Library and www.clinicaltrials.gov w...

Bibliografiset tiedot
Päätekijät:	Wu, S, Cipriani, A, Yang, Z, Yang, J, Cai, T, Xu, Y, Quan, X, Zhang, Y, Chai, S, Sun, F, Zhan, S
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Taylor and Francis 2018

Samankaltaisia teoksia

The effects of incretin‐based therapies on beta‐cell function and insulin resistance in type 2 diabetes: a systematic review and network meta‐analysis combining 360 trials
Tekijä: Wu, S, et al.
Julkaistu: (2019)

Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Tekijä: Je-Yon Kim, et al.
Julkaistu: (2016-01-01)

Correction: Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Tekijä: Je-Yon Kim, et al.
Julkaistu: (2018-01-01)

Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies
Tekijä: Sanbao Chai, et al.
Julkaistu: (2023-07-01)

Incretin-based therapies for patients with type 1 diabetes: a meta-analysis
Tekijä: Lili Liu, et al.
Julkaistu: (2019-03-01)

Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review
Tekijä: Teodor Salmen, et al.
Julkaistu: (2024-10-01)

Effects of incretin-based therapies on β-cell function in type 1 diabetes mellitus: a systematic review and meta-analysis
Tekijä: Yucheng Wu, et al.
Julkaistu: (2021-12-01)

Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
Tekijä: Rikke Viggers, et al.
Julkaistu: (2023-11-01)

Understanding the Cardiovascular Effects of Incretin
Tekijä: Ji Sung Yoon, et al.
Julkaistu: (2011-10-01)

Role of incretin‐based therapy in hospitalized patients with type 2 diabetes
Tekijä: Abraham Edgar Gracia‐Ramos
Julkaistu: (2020-03-01)

Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
Tekijä: Federico Bernardini, et al.
Julkaistu: (2023-07-01)

Role of incretins in the pathogenesis of type 2 diabetes
Tekijä: Radojčin Dragan, et al.
Julkaistu: (2018-01-01)

Achieving equitable access to incretin-based therapies in cardiovascular care
Tekijä: Tina K. Reddy, et al.
Julkaistu: (2024-10-01)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
Tekijä: Stanley Schwartz, et al.
Julkaistu: (2010-07-01)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
Tekijä: Schwartz S
Julkaistu: (2010-07-01)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Tekijä: Joan Khoo, et al.
Julkaistu: (2009-08-01)

Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
Tekijä: Haining Wang, et al.
Julkaistu: (2019-05-01)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
Tekijä: Akira Mima
Julkaistu: (2016-01-01)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
Tekijä: Yu Mi Kang, et al.
Julkaistu: (2017-09-01)

Exposure–Response Analysis of Cardiovascular Outcome Trials With Incretin-Based Therapies
Tekijä: Qi Pan, et al.
Julkaistu: (2022-05-01)

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus
Tekijä: Cobble Michael
Julkaistu: (2012-03-01)

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
Tekijä: Bhaskar Pal, et al.
Julkaistu: (2024-01-01)

Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
Tekijä: Mansur, Sity Aishah
Julkaistu: (2015)

Role of incretin based therapies in the treatment of diabetic kidney disease
Tekijä: Paola Fioretto, et al.
Julkaistu: (2018-11-01)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
Tekijä: Hirotaka Araki, et al.
Julkaistu: (2023-02-01)

Innovations in the treatment of type 2 diabetes mellitus: use of incretins
Tekijä: Ivan Ivanovich Dedov, et al.
Julkaistu: (2010-10-01)

Incretin response in Asian type 2 diabetes: Are Indians different?
Tekijä: Awadhesh Kumar Singh
Julkaistu: (2015-01-01)

Gut hormones, incretin mimetics and gliptins: new understanding and novel therapies in type 2 diabetes.
Tekijä: Munro, N, et al.
Julkaistu: (2007)

Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model
Tekijä: Sanbao Chai, et al.
Julkaistu: (2023-01-01)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
Tekijä: Soyeon Yoo, et al.
Julkaistu: (2019-08-01)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
Tekijä: Jens Juul Holst
Julkaistu: (2019-04-01)

Recent advances in incretin-based therapies.
Tekijä: Russell-Jones, D, et al.
Julkaistu: (2012)

Incretin-based therapy: renal effects
Tekijä: Anton Ivanovich Korbut, et al.
Julkaistu: (2016-01-01)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
Tekijä: Geke Aline Boer, et al.
Julkaistu: (2020-12-01)

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Tekijä: Chang Ho Ahn, et al.
Julkaistu: (2023-02-01)

Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Tekijä: Catherine A Schnabel, et al.
Julkaistu: (2006-03-01)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
Tekijä: Tomohiko Kimura, et al.
Julkaistu: (2021-07-01)

Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
Tekijä: T. Y. Demidova, et al.
Julkaistu: (2022-03-01)

The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
Tekijä: Juris J. Meier
Julkaistu: (2019-12-01)

Inflammation and Incretins
Tekijä: Amitabh Hatwal
Julkaistu: (2012-01-01)